Efficacy and safety of etanercept in children and adolescents aged ≥ 8 years with severe plaque psoriasis

Medicine and Dentistry

• Etanercept 90%
• Placebo 80%
• Psoriasis Area and Severity Index 50%
• Child 40%
• Psoriasis Vulgaris 30%
• Psoriasis 20%
• Analysis 20%
• Therapeutic Procedure 20%
• Diseases 10%
• Adverse Event 10%
• Population Research 10%
• Disease Severity 10%
• Body Surface 10%
• Tumor Necrosis Factor Receptor 10%
• Assessment 10%
• Physician 10%
• Adolescent 10%
• Amaurosis 10%
• Arm 10%

INIS

• psoriasis 100%
• children 40%
• safety 30%
• diseases 20%
• populations 20%
• humans 10%
• assessments 10%
• comparative evaluations 10%
• receptors 10%
• europe 10%
• adolescents 10%
• surface area 10%
• tumor necrosis factor 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Etanercept 90%
• Psoriasis Vulgaris 30%
• Psoriasis 20%
• Diseases 10%
• Adverse Event 10%
• Disease Severity 10%
• Tumor Necrosis Factor Receptor 10%
• Blindness 10%